1st Quarter - Report

AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY for AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY

Firm
Client
Income
—
Expenses
$126,636
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement issues, Merit-Based Incentive Payment System (MIPS), advanced alternative payments models (APMs), Quality Payment Program (QPP), misvalued codes, ambulatory surgery centers, ophthalmic legislation, FDA-related issues, compounded drug issues, quality issues, off-label communication, health information technology, healthcare reform, health insurer anti-trust issues, prior authorization and step therapy, evaluation & management codes, add-on codes.

LobbyistCovered position, as disclosed
NANCEY MCCANN Director of Government Relations

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.